Live Breaking News & Updates on Swissmedic

Stay informed with the latest breaking news from Swissmedic on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Swissmedic and stay connected to the pulse of your community

Orchard Therapeutics Gets Swissmedic Approval For Libmeldy In Early-onset MLD

Gene therapy leader Orchard Therapeutics plc (ORTX) announced Monday the Swiss Agency for Therapeutic Products (Swissmedic) has approved Libmeldy (atidarsagene autotemcel), a hematopoietic stem cell (HSC) gene therapy, for the treatment of early-onset metachromatic leukodystrophy (MLD).

Swiss-agency-for-therapeutic-products-swissmedic , Orchard-therapeutics , Swiss-agency , Therapeutic-products , Swissmedic , Rchard-therapeutics , Ibmeldy , Rtx , Ene-therapy-leader-orchard-therapeutics , Tidarsagene-autotemcel ,

Swiss Drugs Regulator Looking Into Bubbles in COVID Booster Vials

BERLIN—Swiss drugs regulator Swissmedic said on Wednesday it is examining potential risks in connection with bubbles that appeared ...

United-states , Switzerland , Berlin , Germany , Swiss , Pfizer , Bubbles , Drugs , Swissmedic , Vaccination , The-epoch-times

Swissmedic Authorizes Novavax COVID-19 Vaccine For Adolescents And As Booster In Adults

WASHINGTON (dpa-AFX) - Novavax Inc. (NVAX) said that Swissmedic, the Swiss Agency for Therapeutic Products, has expanded its temporary authorization of Nuvaxovid (NVX-CoV2373) COVID-19 vaccine

Switzerland , Washington , United-states , Swiss , Swiss-agency-for-therapeutic-products , Drug-administration , More-such-health-news , Novavax-inc , Swiss-agency , Therapeutic-products , Swissmedic

Swissmedic Approves Roche's Ronapreve to Treat COVID-19 Patients

ZURICH—Swiss drugs regulator Swissmedic said on Monday it approved Ronapreve, an antibody treatment jointly developed by Roche and ...

Zurich , Züsz , Switzerland , Swiss , Covid-19 , Roche , Ronapreve , Swissmedic , The-epoch-times ,

Klein, aber mächtig: Auf der «Power List» der Augenheilkunde steht die Schweiz auf der Spitzenposition

Klein, aber mächtig: Auf der «Power List» der Augenheilkunde steht die Schweiz auf der Spitzenposition
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Zurich , Züsz , Switzerland , Vienna , Wien , Austria , Brussels , Bruxelles-capitale , Belgium , Singapore , Winterthur , Swiss

Kinderwunsch in Spanien: Liberale Gesetze und langjährige Erfahrung

Kinderwunsch in Spanien: Liberale Gesetze und langjährige Erfahrung
annabelle.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from annabelle.ch Daily Mail and Mail on Sunday newspapers.

Germany , Italy , Austria , Russia , Spain , France , Switzerland , Italian , Russian , Austrian , French , Spanish

Coronavirus updates LIVE: Volunteers needed for trial which will 'mix and match' vaccines

Coronavirus updates LIVE: Volunteers needed for trial which will 'mix and match' vaccines
chroniclelive.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chroniclelive.co.uk Daily Mail and Mail on Sunday newspapers.

South-africa , Frankley , Worcestershire , United-kingdom , United-states , Penshaw , Sunderland , Switzerland , Gateshead , America , South-african , British

Coronavirus latest news: Community transmission now the key to lifting lockdown, insists Sage scientist

Coronavirus latest news: UK 'getting safer every day' as almost 1 in 5 adults have had first vaccine, says Nadhim Zahawi
Read full article
Oops!
The UK is "getting safer every day" as almost one in five adults have now had their first dose of the coronavirus vaccine, Nadhim Zahawi has said.
The NHS is on track to meet its target of vaccinating the top four priority groups by mid-February through a "close focus on the most vulnerable", the vaccines minister told MPs.
More than nine in 10 people over the age of 80 have now had their first dose of the vaccine, as have nine in 10 over-75s and over half of all over-70s.

Norway , Australia , United-states , United-kingdom , South-africa , Melbourne , Victoria , London , City-of , Rochdale , Germany , India

Vaccines minister declines to say when over-50s will receive a Covid-19 jab

The vaccines minister has declined to put a date on when all over-50s can expect to receive a Covid-19 jab but figures suggest late March may be an option if supplies continue.
Nadhim Zahawi said a target would be set for reaching all those aged 50 to 70, as well as those with underlying conditions which put them at higher risk of serious disease, once the most vulnerable have been offered a jab by February 15.
Previously, NHS England chief executive Sir Simon Stevens has said the aim is for all over-50s and those at risk to be vaccinated by the end of April.

United-kingdom , South-africa , United-states , France , Switzerland , America , Swiss , Matt-hancock , Andrew-hayward , Jonathan-van-tam , Nadhim-zahawi , Claus-bolte

Covid-19 : la Suisse demande de nouvelles études pour le vaccin d'AstraZeneca

Covid-19 : la Suisse demande de nouvelles études pour le vaccin d'AstraZeneca
ladepeche.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ladepeche.fr Daily Mail and Mail on Sunday newspapers.

Germany , Italy , Portugal , United-kingdom , France , Switzerland , British , Swiss , Pfizer , Johnson-will , Biontech-and-in-switzerland